Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 588 participants.

Also called NCT06250712

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 588 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06250712
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06250712. Randomized; no masking; primary purpose diagnostic. Start 2024-02-22 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hativ® ELectrocardiogram Monitoring on Patients With Suspected Arrhythmia
Acronym
HELP-A
Condition
Arrhythmia
Intervention (Device)
Memo Patch continuous ECG (electrocardiogram)
Intervention (Device)
Hativ handheld ECG
Lead sponsor
Wonju Severance Christian Hospital (class: other)

Record details

Record id
cardio:ct-nct06250712
Content hash
da83b1ef66c2b928c604e1fe68860bb4ae2f5f9b9bd1038f04a1b138cfb0c33f